PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2012Journal of Nuclear Medicine268 citationsOpen Access

Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT

KRKambiz RahbarHSHarald SeifarthMSMichael Schäfers

Structured PICO

Does 18F-FDG PET/CT aid in the differentiation of malignant and benign cardiac tumors?

P
Population
Patients with cardiac tumors
I
Intervention
18F-FDG PET/CT
O
Outcome
Preoperative determination of malignancy and detection of metastasessurrogate

18F-FDG PET/CT may be a useful noninvasive tool for differentiating malignant from benign cardiac tumors and detecting metastases.

Abstract

(18)F-FDG PET/CT can aid the noninvasive preoperative determination of malignancy and may be helpful in detecting metastases of malignant cardiac tumors.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rahbar et al. (2012) studied this question.

synapsesocial.com/papers/69db1de61e19c8ae088365f3https://doi.org/10.2967/jnumed.111.095364
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Motion Correction in Respiratory Gated Cardiac PET/CT Using Multi-scale Optical Flow2008 · 24 citations
  2. 2Fluorodeoxyglucose–Positron Emission Tomography Differentiating Thrombus From Tumor in the Left Ventricle2009 · 4 citations
  3. 3Recommendations on the Use of 18 F-FDG PET in Oncology2008 · 1,105 citations
  4. 4Therapy refractory coronary compression caused by a cardiac metastasis: The role of imaging2009 · 5 citations
  5. 5Assessing Tumor Response to Therapy2009 · 272 citations